http://web.archive.org/web/20150720075532id_/http://www.dailymail.co.uk/news/article-2980025/Nurofen-s-headache-Consumer-watchdog-takes-pain-killer-court-claiming-products-treat-different-forms-pain-contain-EXACTLY-ingredients.html

one of @entity1 's most popular pain killers has been left with a splitting headache , as the national consumer watchdog gets ready to take it to court			0
@entity6 , the company behind @entity7 in @entity1 , will square off against the @entity8 ( @entity8 ) in federal court this month over claims that it has mislead customers			1
the @entity8 will dispute claims made by the company that the @entity13 is specially designed to target different types of pain			1
the consumer watchdog claims that all products contain identical ingredients			0
@entity8 chairman @entity32 said cracking down on false advertising surrounding medical products was a targetted priority for the watchdog			1
' the @entity8 takes false or misleading claims about the efficacy of health and medical products very seriously , ' mr @entity32 said			1
' in this case , we allege that consumers have been misled into purchasing @entity44 under the belief that each product is specifically designed for and effective in treating a particular type of pain , when this is not the case			0
' ' the @entity8 takes false or misleading claims about the efficacy of health and medical products very seriously , ' chairman @entity32 said			1
it also flagged the ' significantly ' higher cost of @entity7 compared to other products as a concern , with the range in question costing up to twice as much as a standard pain killer sold by @entity7 or another comparable brand			2
a @entity7 spokeswoman denied the allegations in a statement , and said pain - specific products made life easier for customers			2
' @entity7 is committed to the quality use of medicines and promoting and protecting the health of @entity1 , ' the statement read			2
' @entity7 works closely with all regulatory bodies to ensure high standards compliance to guidelines			0
' @entity7 will continue to work with regulators to ensure its packaging continues to be fully aligned with all guidelines and requirements and still offer consumers with clear pain relief options for their pain type			0
' the @entity8 is seeking declarations , injunctions , an order for the publication of corrective notices , penalties and costs			0
the matter is listed for a case management conference in the @entity87 in @entity88 on march 31 .			1

@entity8 takes it to federal court
alleges @entity7 claims ' misleading customers ' , all *tablets* exactly the same
@entity8 says all *pills* have the same *key* ingredient , *ibuprofen* *lysine* *342mg*
calls for ' truth in advertising ' across medical *industry* to become priority
case to go before @entity87 in @entity88 on march 31

@entity31:Nurofen Tension Headache
@entity30:Nurofen Migraine Pain
@entity1:Australians
@entity8:ACCC
@entity13:Nurofen Specific Pain Range
@entity6:Reckitt Benckiser
@entity28:Nurofen Back Pain
@entity29:Nurofen Period Pain
@entity44:Nurofen Specific Pain Products
@entity32:Rod Sims
@entity87:Federal Court of Australia
@entity88:Sydney
@entity7:Nurofen